24-hour IOP-lowering Effect of Brimonidine 0.1%

Clinical trial NCT00457795 · COMPLETED

Trial details

NCT number: NCT00457795
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Open-angle Glaucoma Ocular Hypertension

Start date: 2006-12-01
Primary completion: 2009-02-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.